Hydrogen sulfide attenuates lipopolysaccharide-induced cognitive impairment: A pro-inflammatory pathway in rats

Pharmacology Biochemistry and Behavior

Volumn 96, Issue 1, 2010, Pages 52-58

  Gong, Qi Hai ^a   Wang, Qian ^a   Pan, Li Long ^a   Liu, Xin Hua ^a   Huang, Hui ^a   Zhu, Yi Zhun ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Alzheimer's disease; Cognitive impairment; H2S; LPS; NF B; TNF

Indexed keywords

AUTACOID; HYDROGEN SULFIDE; I KAPPA B ALPHA; IBUPROFEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; ESCAPE BEHAVIOR; HIPPOCAMPUS; LATENT PERIOD; MALE; MAZE TEST; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TASK PERFORMANCE; TREATMENT DURATION; WESTERN BLOTTING;

ALZHEIMER DISEASE; ANIMALS; COGNITION DISORDERS; HYDROGEN SULFIDE; INFLAMMATION; LIPOPOLYSACCHARIDES; MALE; RATS; RATS, SPRAGUE-DAWLEY;

RATTUS;

EID: 77953286076     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2010.04.006     Document Type: Article

References (44)

1. Abe K., Kimura H. The possible role of hydrogen sulfide as an endogenous neuromodulator. J Neurosci 1996, 16:1066-1071.
2. Akiyama H., Barger S., Barnum S., Bradt B., Bauer J., Cole G.M., et al. Inflammation and Alzheimer's disease. Neurobiol Aging 2000, 21:383-421.
3. Alvarez A., Cacabelos R., Sanpedro C., García-Fantini M., Aleixandre M. Serum TNF-alpha levels are increased and correlate negatively with free IGF-I in Alzheimer disease. Neurobiol Aging 2007, 28:533-536.
4. Chuah S.C., Moore P.K., Zhu Y.Z. S-allylcysteine mediates cardioprotection in an acute myocardial infarction rat model via a hydrogen sulfide-mediated pathway. Am J Physiol Heart Circ Physiol 2007, 293:H2693-H2701.
5. Flick D.A., Gifford G.E. Production of tumor necrosis factor in unprimed mice: mechanism of endotoxin-mediated tumor necrosis. Immunobiology 1986, 171:320-328.
6. Goodwin L.R., Francom D., Dieken F.P., Taylor J.D., Warenycia M.W., Reiffenstein R.J., et al. Determination of sulfide in brain tissue by gas dialysis/ion chromatography: postmortem studies and two case reports. J Anal Toxicol 1989, 13:105-109.
7. Ghosh S., Karin M. Missing pieces in the NF-kappaB puzzle. Cell 2002, 109:S81-S96.
8. Gong Q.H., Wu Q., Huang X.N., Sun A.S., Shi J.S. Protective effects of Ginkgo biloba leaf extract on aluminum-induced brain dysfunction in rats. Life Sci 2005, 77:140-148.
9. Hauss-Wegrzyniak B., Lukovic L., Bigaud M., Stoeckel M.E. Brain inflammatory response induced by intracerebroventricular infusion of lipopolysaccharide: an immunohistochemical study. Brain Res 1998, 794:211-214.
10. He P., Zhong Z., Lindholm K., Berning L., Lee W., Lemere C., et al. Deletion of tumor necrosis factor death receptor inhibits amyloid beta generation and prevents learning and memory deficits in Alzheimer's mice. J Cell Biol 2007, 178:829-841.
11. Hu L.F., Wong P.T., Moore P.K., Bian J.S. Hydrogen sulfide attenuates lipopolysaccharide-induced inflammation by inhibition of p38 mitogen-activated protein kinase in microglia. J Neurochem. 2007, 100:1121-1128.
12. Kim W.G., Mohnev R.P., Wilson B., Jeohn G.H., Liu B., Hong L.S. Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia. J Neurosci. 2000, 20:6309-6316.
13. Kimura Y., Kimura H. Hydrogen sulfide protects neurons from oxidative stress. FASEB J 2004, 18:1165-1167.
14. Kitazawa M., Oddo S., Yamasaki T.R., Green K.N., LaFerla F.M. Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer's disease. J Neurosci 2005, 25:8843-8853.
15. Koenigsknecht-Talboo J., Landreth G.E. Microglial phagocytosis induced by fibrillar beta-amyloid and IgGs are differentially regulated by proinflammatory cytokines. J Neurosci 2005, 25:8240-8249.
16. Kimura H., Nagai Y., Umemura K., Kimura Y. Physiological roles of hydrogen sulfide: synaptic modulation, neuroprotection, and smooth muscle relaxation. Antioxid Redox Signal 2005, 7:795-803.
17. Li Q., Verma I.M. NF-kappaB regulation in the immune system. Nat Rev Immunol 2002, 2:725-734.
18. Li L., Bhatia M., Zhu Y.Z., Zhu Y.C., Ramnath R.D., Wang Z.J., et al. Hydrogen sulfide is a novel mediator of lipopolysaccharide-induced inflammation in the mouse. FASEB J 2005, 19:1196-1198.
19. Loh K.P., Huang S.H., De Silva R., Tan B.K., Zhu Y.Z. Oxidative stress: apoptosis in neuronal injury. Curr Alzheimer Res 2006, 3:327-337.
20. Li L., Bhatia M., Moore P.K. Hydrogen sulphide - a novel mediator of inflammation?. Curr Opin Pharmacol 2006, 6:125-129.
21. Lee J.W., Lee Y.K., Yuk D.Y., Choi D.Y., Ban S.B., Oh K.W., et al. Neuro-inflammation induced by lipopolysaccharide causes cognitive impairment through enhancement of beta-amyloid generation. J Neuroinflammation 2008, 5:37.
22. Liu X.Q., Liu X.Q., Jiang P., Huang H., Yan Y. Plasma levels of endogenous hydrogen sulfide and homocysteine in patients with Alzheimer's disease and vascular dementia and the significance thereof. Chin Med J 2008, 88:2246-2249.
23. Liu X.H., Chen P.F., Pan L.L., Zhu Y.Z. 4-Guanidino-n-butyl syringate (leonurine) protects H9c2 rat ventricular cells from hypoxia-induced apoptosis. J Cardiovasc Pharmacol 2009, 54:437-444.
24. Lee M., Schwab C., Yu S., McGeer E., McGeer P.L. Astrocytes produce the antiinflammatory and neuroprotective agent hydrogen sulfide. Neurobiol Aging 2009, 30:1523-1534.
25. Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods 1984, 11:47-60.
26. McAlpine F.E., Tansey M.G. Neuroinflammation and tumor necrosis factor signaling in the pathophysiology of Alzheimer's disease. J Inflam Res 2008, 1:29-39.
27. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 1997, Academic Press, San Diego. 2nd edn.
28. Qu K., Chen C.P., Halliwell B., Moore P.K., Wong P.T. Hydrogen sulfide is a mediator of cerebral ischemic damage. Stroke 2006, 37:889-893.
29. Qin L., Wu X., Block M.L., Liu Y., Breese G.R., Hong J.S., et al. Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia 2007, 55:453-462.
30. Reiffenstein R.J., Hulbert W.C., Roth S.H. Toxicology of hydrogen sulfide. Annu Rev Pharmacol Toxicol 1992, 32:109-134.
31. Rosi S., Ramirez-Amaya V., Vazdarjanova A., Worley R.F., Barnes G.A., Wenk G.L. Neuroinflammation alters the hippocampal pattern of behaviorally induced Arc expression. J Neurosci 2005, 25:723-731.
32. Savage J.C., Gould D.H. Determination of sulfide in brain tissue and rumen fluid by ion-interaction reversed-phase high-performance liquid chromatography. J Chromatogr 1990, 526:540-545.
33. Sha W.C. Regulation of immune responses by NF-kappa B/Rel transcription factor. J Exp Med 1998, 187:143-146.
34. Tanaka S., Ide M., Shibutani T., Ohtaki H., Numazawa S., Shioda S., et al. Lipopolysaccharide-induced microglial activation induces learning and memory deficits without neuronal cell death in rats. J Neurosci Res 2006, 83:557-566.
35. Tobinick E., Gross H., Weinberger A. Cohen H.TNF-alpha modulation for treatment of Alzheimer's disease: a 6-month pilot study. MedGenMed 2006, 8:25.
36. Tan Z.S., Beiser A.S., Vasan R.S., Roubenoff R., Dinarello C.A., Harris T.B., et al. Inflammatory markers and the risk of Alzheimer disease: the Framingham Study. Neurology 2007, 68:1902-1908.
37. Tang X.Q., Yang C.T., Chen J., Yin W.L., Tian S.W., Hu B., et al. Effect of hydrogen sulphide on beta-amyloid-induced damage in PC12 cells. Clin Exp Pharmacol Physiol 2008, 35:180-186.
38. Versijpt J.J., Dumont F., Van Laere K.J., Decoo D., Santens P., Audenaert K., et al. Assessment of neuroinflammation and microglial activation in Alzheimer's disease with radiolabelled PK11195 and single photon emission computed tomography. A pilot study. Eur Neurol 2003, 50:39-47.
39. Venneti S., Wiley C.A., Kofler J. Imaging microglial activation during neuroinflammation and Alzheimer's disease. J Neuroimmune Pharmacol 2009, 4:227-243.
40. Warenycia M.W., Goodwin L.R., Benishin C.G., Reiffenstein R.J., Francom D.M., Taylor J.D., et al. Acute hydrogen sulfide poisoning. Demonstration of selective uptake of sulfide by the brainstem by measurement of brain sulfide levels. Biochem Pharmacol 1989, 38:973-981.
41. Wang R. The gasotransmitter role of hydrogen sulfide. Antioxid Redox Signal 2003, 5:493-501.
42. Wajant H., Pfizenmaier K., Scheurich P. Tumor necrosis factor signaling. Cell Death Differ 2003, 10:45-65.
43. Wang Q., Liu H.R., Mu Q., Rose P., Zhu Y.Z. S-propargyl-cysteine protects both adult rat hearts and neonatal cardiomyocytes from ischemia/hypoxia injury: the contribution of the hydrogen sulfide-mediated pathway. J Cardiovasc Pharmacol 2009, 54:139-146.
44. Zhu Y.Z., Wang Z.J., Ho P., Loke Y.Y., Zhu Y.C., Huang S.H., et al. Hydrogen sulfide and its possible roles in myocardial ischemia in experimental rats. J Appl Physiol 2007, 102:261-268.